I agree, only a matter of weeks before OVATURE. If a phase III trial for a pan-acting cancer agent with an excellent safety profile can't excite the market then nothing will. Have a feeling many investors have just lost interest due to ongoing delays... but if results are positive, then we could be in for a really nice ride.
I agree, only a matter of weeks before OVATURE. If a phase III...
Add to My Watchlist
What is My Watchlist?